NEJM - Spiroindolone KAE609 for Falciparum and Vivax Malaria

"Spiroindolone KAE609 for Falciparum and Vivax Malaria"
"CONCLUSIONS

KAE609, at dose of 30 mg daily for 3 days, cleared parasitemia rapidly in adults with uncomplicated P. vivax or P. falciparum malaria. (Funded by Novartis and others; ClinicalTrials.gov number,NCT01524341.)" 

http://www.nejm.org/doi/full/10.1056/NEJMoa1315860